Followers | 1 |
Posts | 70 |
Boards Moderated | 0 |
Alias Born | 02/27/2019 |
Saturday, February 22, 2020 8:34:40 AM
However, as way of perspective, Exactus spent $2,052,677 just in the 3rd quarter on General/Administrative/Professional/Consulting expenses. On such background, this guy wouldn't be the top of my concerns.
Right now their e-commerce site, exactushemp.com, is not on anyone's radar. It can't be found on any aggregated Lists of CBD e-vendors:
https://cbdnerds.com/reviews/cbd-reviews
https://www.austinchronicle.com/daily/events/2020-01-23/50-best-cbd-oil-companies-of-2020/
This kid is bright, personable, former actor... maybe, just maybe, this is the type of person who can generate the buzz and publicity to put their brand on the map. In any case, his compensation is disclosed, the guy is willing to put himself in front of a camera from the get-go, and people have enough information to form opinions of whether he is worth the money or not.
On the other hand, you don't have much transparency on whether the other $2M+ of overhead burn per quarter is spent on productive activities to create value. Frankly, it is highly questionable for a micro-farmer with an obscure website to burn through $2M+ on quarter in overhead...
Recent PLSH News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 03:28:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 07:24:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/08/2023 08:04:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 05:07:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:15:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 04:21:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 03:28:18 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 03:19:11 PM
- Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast • InvestorsHub NewsWire • 07/18/2023 04:41:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 01:00:13 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM